Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AHCO logo AHCO
Upturn stock ratingUpturn stock rating
AHCO logo

Adapthealth Corp (AHCO)

Upturn stock ratingUpturn stock rating
$9.43
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

8 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $12.88

1 Year Target Price $12.88

Analysts Price Target For last 52 week
$12.88Target price
Low$7.11
Current$9.43
high$11.9

Analysis of Past Performance

Type Stock
Historic Profit -74.24%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.29B USD
Price to earnings Ratio 16.54
1Y Target Price 12.88
Price to earnings Ratio 16.54
1Y Target Price 12.88
Volume (30-day avg) 8
Beta 1.64
52 Weeks Range 7.11 - 11.90
Updated Date 07/1/2025
52 Weeks Range 7.11 - 11.90
Updated Date 07/1/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.57

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 2.63%
Operating Margin (TTM) 3.63%

Management Effectiveness

Return on Assets (TTM) 3.82%
Return on Equity (TTM) 5.9%

Valuation

Trailing PE 16.54
Forward PE 9.53
Enterprise Value 3323528185
Price to Sales(TTM) 0.4
Enterprise Value 3323528185
Price to Sales(TTM) 0.4
Enterprise Value to Revenue 1.02
Enterprise Value to EBITDA 5.41
Shares Outstanding 134948000
Shares Floating 89408354
Shares Outstanding 134948000
Shares Floating 89408354
Percent Insiders 8.03
Percent Institutions 102.26

Analyst Ratings

Rating 2
Target Price 12.88
Buy 1
Strong Buy 5
Buy 1
Strong Buy 5
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Adapthealth Corp

stock logo

Company Overview

overview logo History and Background

AdaptHealth Corp. (formerly known as DFB Healthcare Acquisitions Corp.) was founded in 2012. It has grown significantly through acquisitions, consolidating fragmented durable medical equipment (DME) and home healthcare services. The company focuses on providing a range of medical equipment and supplies, focusing on respiratory, mobility, and sleep therapy solutions.

business area logo Core Business Areas

  • Respiratory Equipment: Provides oxygen therapy, ventilation equipment, and related supplies to patients with respiratory conditions.
  • Sleep Therapy Equipment: Offers CPAP and BiPAP machines, masks, and accessories for patients with sleep apnea.
  • Mobility Equipment: Supplies wheelchairs, mobility scooters, walkers, and other assistive devices for individuals with mobility impairments.
  • Home Medical Equipment (HME): A broad category that includes various types of durable medical equipment used in the home setting, addressing diverse patient needs beyond respiratory, sleep and mobility.

leadership logo Leadership and Structure

The leadership team includes Stephen Griggs (CEO) and Josh Loyd (CFO). The organizational structure is built around regional operations and centralized support functions like billing and IT.

Top Products and Market Share

overview logo Key Offerings

  • CPAP and BiPAP Machines: Provides CPAP machines and related supplies for sleep apnea treatment. Market share data is difficult to pinpoint exactly, but Adapthealth is a major player in the market. Competitors include ResMed, Philips (Recalled devices have impacted them), and Lincare.
  • Oxygen Concentrators and Supplies: Supplies oxygen therapy equipment and related supplies for respiratory conditions. Market share data is not precise, but it is a key growth product for the company. Competitors include Lincare, Apria Healthcare (Owens & Minor), and national and regional DME providers.
  • Mobility Equipment (Wheelchairs, Scooters): Supplies a wide range of manual and power wheelchairs, mobility scooters, and accessories. Market share in this segment is fragmented among many regional and national suppliers. Competitors include Numotion, National Seating & Mobility, and local DME providers.

Market Dynamics

industry overview logo Industry Overview

The DME market is experiencing growth driven by an aging population, rising prevalence of chronic diseases, and increasing demand for home-based healthcare solutions. The industry is consolidating, with larger players acquiring smaller providers.

Positioning

AdaptHealth Corp. is positioned as a leading provider of DME and related services, with a focus on respiratory, sleep, and mobility solutions. Its competitive advantages include its scale, geographic reach, and relationships with healthcare providers.

Total Addressable Market (TAM)

The global durable medical equipment market is expected to reach approximately $280 billion by 2028. AdaptHealth is well-positioned to capture a portion of this TAM through organic growth and acquisitions.

Upturn SWOT Analysis

Strengths

  • Large scale and market presence
  • Strong relationships with healthcare providers
  • Diversified product and service offerings
  • Proven track record of acquisitions

Weaknesses

  • High debt levels
  • Dependence on reimbursement rates
  • Integration risks associated with acquisitions
  • Exposure to regulatory changes

Opportunities

  • Further consolidation of the DME market
  • Expansion into new geographic markets
  • Development of new products and services
  • Increased adoption of telehealth and remote patient monitoring

Threats

  • Changes in reimbursement policies
  • Increased competition
  • Economic downturns
  • Product liability risks

Competitors and Market Share

competitor logo Key Competitors

  • RESM
  • OMC
  • ITGR

Competitive Landscape

AdaptHealth competes on scale, geographic reach, and product offerings. Its advantages include its established relationships with healthcare providers and its ability to integrate acquisitions. Its disadvantages include its high debt levels and exposure to reimbursement pressures.

Major Acquisitions

AeroCare Holdings

  • Year: 2021
  • Acquisition Price (USD millions): 2000
  • Strategic Rationale: Expanded AdaptHealth's geographic footprint and strengthened its position in the respiratory and sleep therapy markets.

Growth Trajectory and Initiatives

Historical Growth: AdaptHealth Corp. has experienced rapid growth through acquisitions and organic expansion. The company has successfully integrated numerous acquisitions and expanded its product and service offerings.

Future Projections: Analysts project continued revenue growth driven by industry trends and the company's acquisition strategy. Profitability is expected to improve as integration costs subside and synergies are realized.

Recent Initiatives: Recent strategic initiatives include focusing on organic growth, improving operational efficiencies, and investing in technology to enhance patient care.

Summary

Adapthealth is a large player in the DME market with significant growth potential, driven by industry trends and acquisitions. While its revenue is strong, its profitability is affected by high debt levels and acquisition costs. The company needs to focus on integrating acquisitions, reducing debt, and improving operational efficiency to achieve sustainable profitability. The company should watch out for reimbursement changes and competition from other large and regional DME suppliers.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (10-K, 10-Q)
  • Investor Presentations
  • Analyst Reports
  • Industry Research Reports

Disclaimers:

This analysis is based on publicly available information and is not financial advice. Market data and projections are subject to change. Investing involves risk; past performance is not indicative of future results.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Adapthealth Corp

Exchange NASDAQ
Headquaters Plymouth Meeting, PA, United States
IPO Launch date 2018-05-24
CEO & Director Ms. Suzanne M. Foster M.P.H.
Sector Healthcare
Industry Medical Devices
Full time employees 10500
Full time employees 10500

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.